Effects of thalidomide on the development of bone damage caused by prednisolone in rats.
Journal Title: Pharmacological Reports - Year 2012, Vol 64, Issue 2
Abstract
Background: The methods used in treatment of osteoporosis induced by glucocorticosteroids are not effective enough. There is a need for new drugs which could be useful in counteracting the influence of glucocorticosteroids on osseous tissue. The aim of the present study was to investigate the effects of thalidomide on the development of osteoporosis induced by glucocorticoid (prednisolone) in rats. Methods: The experiments were carried out on 3-month-old male Wistar rats. The animals were divided into 4 groups: I - control rats; II - prednisolone (10 mg/kg po); III - prednisolone (10 mg/kg po) + thalidomide (15 mg/kg po); IV - prednisolone (10 mg/kg po) + thalidomide (60 mg/kg po). The drugs were administered for 3 weeks. The body mass gain, bone mass in the tibia, femur and L-4 vertebra, histomorphometric parameters of the tibia (width of osteoid, diaphysis transverse growth, area of the transverse cross-sectional of the bone marrow cavity and the cortical bone) and the femur (width of trabeculae, width of epiphyseal cartilage, diaphysis transverse growth, area of the transverse cross-sectional of the bone marrow cavity and the cortical bone) were studied. Results: Prednisolone induced osteoporotic skeletal changes in mature male rats (decreases in the bone mass, the width of the periosteal and endosteal osteoid, the transverse cross-sectional area of the cortical bone, the width of trabeculae, and the diaphysis transverse growth were observed). Thalidomide administered at a dose of 15 mg/kg po inhibited the development of changes in macrometric and histomorphometric parameters induced by prednisolone in the skeletal system of rats. Conclusion: The results may constitute indirect evidence for possible clinical trials conducted in order to define the possibility to apply thalidomide in treatment of bone diseases in humans.
Authors and Affiliations
Ilona Kaczmarczyk-Sedlak, Maria Zych, Katarzyna Rotko, Lech Sedlak
Keywords
Related Articles
- EP ID EP92689
- DOI -
- Views 99
- Downloads 0
Effect of kaempferol on the production and gene expression of monocyte chemoattractant protein-1 in J774.2 macrophages.
Monocyte chemoattractant protein-1 (MCP-1) is produced by activated macrophages, and is involved in pathogenesis of cardiovascular and neurodegenerative disorders. There is a need to develop drugs that inhibit excessive...
Research advances in basic mechanisms of seizures and antiepileptic drug action.
Epilepsy is a common neurological disease but the mechanism of seizure generation has been only partially unraveled. Furthermore, almost 30% of epileptic patients are resistant to pharmacological treatment. Therefore, el...
Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats.
It has been recognized that the stress-related peptides are involved in anxiety states. Angiotensin II receptor blockade by systemic administration of the AT(1) receptor antagonists has been proposed as a new treatment p...
Long-term use of low-dose spironolactone in spontaneously hypertensive rats: Effects on left ventricular hypertrophy and stiffness.
The aim of the present study was to evaluate the effect of low-dose spironolactone initiated during the early stages of hypertension development and to assess the effects of chronic pressure overload on ventricular remod...
Versatile effects of sildenafil: recent pharmacological applications.
Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor and is predominantly used in the treatment of erectile dysfunction. While maintaining an excellent safety and tolerability profile in the management of erectile dysfun...